Merrimack Pharmaceuticals Secures $77,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8370e71d-2d5b-44c8-b5bc-d90cdcac10ac&Preview=1
Date
4/14/2011
Company Name
Merrimack Pharmaceuticals
Mailing Address
One Kendall Square Cambridge, MA 02139
Company Description
Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer.
Website
http://www.merrimackpharma.com
Transaction Type
Venture Equity
Transaction Amount
$77,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used to advance Merrimack’s proprietary pipeline of novel targetedcancer therapeutics.
M&A Terms
Venture Investor
Undisclosed